Nivolumab,Ipilimumab,Cabozantinib,Sunitinib
BMS,Pfizer
['thank you', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
the future of #kidneycancer research looks bright after #gu23! the insights and ideas presented by the world's best researchers inspire us as we continue our mission of #acceleratingcures. thank you, asco, for another informative conference showcasing extraordinary work! 
Our mission is to accelerate cures for #kidneycancer. We educate patients about clinical trials, advocate for research funding, and bring researchers together.